17 results
management differential medications causes comparison euglycemic high hyperkalemia nephrology potassium table toxicity acromegaly agonists anthracycline based calculation carbratio cardiology cardiotoxicity
Diabetes Medications Summary Table Insulin Lifestyle modifications Metformin Sulfonylureas GLP-1 receptor agonists - ↓ major adverse CV events TZDs DPP-4 inhibitors SGLT2 inhibitors -
Diabetes Medications ... Summary Table Insulin ... SGLT2 inhibitors ... comparison #management #endocrinology ... #dm2
Diabetes Mellitus Type 2 Inpatient Medication Guide Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
receptor agonist, SGLT2i ... mealtime • If NPO ... #Mellitus #DM2 ... #Medications #pharmacology ... comparison #table #endocrinology
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... - Pharmacology ... #Inhibitors #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
SGLT2 Inhibitors and Euglycemic DKA Risk factors for euglycemic DKA in those on an SGLT2i include: •
SGLT2 Inhibitors ... alcohol consumption Diagnostic ... include: • Serum pH ... serum or urine Treatment ... inhibitor should
Oral Hypoglycemics in Diabetes Management 1 INSULIN SENSITIZER • TZD -
Hypoglycemics in Diabetes ... Management 1 INSULIN ... Prandase) • SGLT ... #Management #pharmacology ... #DM2 #DMII #Classification
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... SGLT2 inhibitors ... #Inhibitors #Pharmacology ... #Medications #DM2 ... #Diabetes #Endocrinology
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing TDD in units of insulin = N
: Weight-Based Dosing ... #dosing #estimation ... Weight #Based #pharmacology ... #endocrinology ... #diabetes #DM2
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... -> Stimulates Insulin ... #Pharmacology #Management ... #Diabetes #DM2 ... #Endocrinology
Euglycemic Diabetic Ketoacidosis (EuDKA) SGLT2 Inhibitors Increasing Indications Significant Adverse Drug Effects Definition of EuDKA • Metabolic acidosis with pH
Ketoacidosis (EuDKA) SGLT2 ... Inhibitors Increasing ... acidosis with pH ... Ketoacidosis #EuDKA #diagnosis ... #management #endocrinology
Ketosis Disorders Ketone bodies are a normal metabolic energy source. Excessive unregulated production of ketones, often accompanied
• Diabetic ketoacidosis ... variant seen with SGLT ... inhibitors & pregnancy ... #differential #diagnosis ... #management #endocrinology
No results found for "NPH endocrinology pharmacology dosing treatment dm2 inhibitors sglt2 diabetes insulin diagnosis"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #NPH #endocrinology #pharmacology #dosing #treatment #dm2 #inhibitors #sglt2 #diabetes #insulin #diagnosis